LUSOCHIMICA SPA

Overview

LUSOCHIMICA SPA is an active pharmaceutical ingredient (API) supplier with 13 active FDA Type II Drug Master Files, covering ALBUTEROL SULFATE; BETAXOLOL HYDROCHLORIDE; CARTEOLOL HYDROCHLORIDE; DILTIAZEM HYDROCHLORIDE; FORMOTEROL FUMARATE DIHYDRATE; GLIBENCLAMIDE (GLYBURIDE).

Core services & business areas

Active pharmaceutical ingredients supplied

Substances LUSOCHIMICA SPA is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

LUSOCHIMICA SPA holds 13 active (26 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• SILVER SULFADIAZINEActive2015-04-01
• ALBUTEROL SULFATEActive2015-03-10
• FORMOTEROL FUMARATE DIHYDRATEActive2010-05-10
• NICARDIPINE HYDROCHLORIDE (INTENDED FOR PARENTERAL USE)Active2008-03-25
• NIMODIPINEActive2000-07-26
• NISOLDIPINEActive1999-07-28
• CARTEOLOL HYDROCHLORIDEActive1997-05-15
• BETAXOLOL HYDROCHLORIDEActive1994-02-04
• NICARDIPINE HYDROCHLORIDEActive1992-01-08
• GLIBENCLAMIDE (GLYBURIDE)Active1991-12-03
• IPRATROPIUM BROMIDEActive1991-02-15
• DILTIAZEM HYDROCHLORIDEActive1986-11-14
• METAPROTERENOL SULFATEActive1984-03-27
• RITODRINE HYDROCHLORIDEInactive1993-06-16
• ACEBUTOLOL HYDROCHLORIDEInactive1991-11-27

Showing 15 of 26 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to LUSOCHIMICA SPA in our records. PharmaTek screens the full directory against live FDA enforcement data.